Ray Dalio Nuvasive Inc Transaction History

Bridgewater Associates, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$36.71 - $44.15 $226,977 - $272,979	-6,183 Reduced 9.71%	57,499 $2.39 Million
Q1 2023 May 12, 2023	BUY	$36.81 - $48.12 $88,417 - $115,584	2,402 Added 3.92%	63,682 $2.63 Million
Q4 2022 Feb 13, 2023	SELL	$35.68 - $44.71 $745,533 - $934,215	-20,895 Reduced 25.43%	61,280 $2.53 Million
Q3 2022 Nov 10, 2022	SELL	$42.51 - $54.02 $4,421 - $5,618	-104 Reduced 0.13%	82,175 $3.6 Million
Q2 2022 Aug 11, 2022	BUY	$46.84 - $59.75 $375,984 - $479,613	8,027 Added 10.81%	82,279 $4.05 Million
Q1 2022 May 13, 2022	BUY	$48.09 - $57.79 $845,374 - $1.02 Million	17,579 Added 31.02%	74,252 $4.21 Million
Q4 2021 Feb 14, 2022	BUY	$47.19 - $62.68 $388,987 - $516,671	8,243 Added 17.02%	56,673 $2.97 Million
Q3 2021 Nov 12, 2021	SELL	$56.91 - $67.81 $219,388 - $261,407	-3,855 Reduced 7.37%	48,430 $2.9 Million
Q2 2021 Aug 13, 2021	BUY	$64.02 - $71.72 $3.35 Million - $3.75 Million	52,285 New	52,285 $3.54 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.